This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: Bayer Healthcare LLC, Second Genome, Inc.. Active years: 2017-2026.
Location History:
- San Ramon, CA (US) (2017 - 2018)
- South San Francisco, CA (US) (2021)
- Danville, CA (US) (2018 - 2023)
Company Filing History:
Years Active: 2017-2026
Title: Ye Jin: Innovator in Therapeutic Proteins
Introduction
Ye Jin is a prominent inventor based in San Ramon, CA, with a remarkable portfolio of seven patents. Her work primarily focuses on therapeutic proteins aimed at treating various gastrointestinal diseases, showcasing her commitment to advancing medical science.
Latest Patents
Ye Jin's latest patents include innovative therapeutic proteins designed for the treatment of epithelial barrier function disorders. These proteins and their pharmaceutical compositions are particularly useful in addressing human gastrointestinal inflammatory diseases. They target conditions associated with decreased epithelial cell barrier function or integrity. Notably, her work is significant for treating inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
Career Highlights
Throughout her career, Ye Jin has made substantial contributions to the field of biotechnology. She has worked with notable companies such as Bayer Healthcare LLC and Second Genome, Inc., where she has applied her expertise in developing groundbreaking therapeutic solutions.
Collaborations
Ye Jin has collaborated with esteemed colleagues, including Terry Hermiston and Andrew Wonhee Han, further enhancing her innovative work in the field.
Conclusion
Ye Jin's contributions to the development of therapeutic proteins represent a significant advancement in the treatment of gastrointestinal diseases. Her dedication to innovation continues to impact the medical community positively.